| Authors: |
Pratz KW; Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., DiNardo CD; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Arellano M; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA., Thirman MJ; Section of Hematology and Oncology, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois, USA., Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, California, USA., Becker PS; Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, California, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Smith BD; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Zhang M; AbbVie Inc., North Chicago, Illinois, USA., Miu K; AbbVie Inc., North Chicago, Illinois, USA., Potluri J; AbbVie Inc., North Chicago, Illinois, USA., Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado, USA. |
